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ABSTRACT Protein microspheres are of particular utility in the ﬁeld of drug delivery. A novel, completely aqueous, process of
microsphere fabrication has been devised based on controlled phase separation of protein from water-soluble polymers such as
polyethylene glycols. The fabrication process results in the formation of spherical microparticles with narrow particle size
distributions. Cooling of preheated human insulin-poly(ethylene glycol)-water solutions results in the facile formation of insulin
particles. Tomap out the supersaturation conditions conducive to particle nucleation and growth, we determined the temperature-
andconcentration-dependent boundariesof anequilibrium liquid-solid phaseseparation. Thekineticsof formation ofmicrospheres
were followed by dynamic and continuous-angle static light scattering techniques. The presence of PEG at a pH that was close to
the protein’s isoelectric point resulted in rapid nucleation and growth. The time elapsed from the moment of creation of a super-
saturated solution and the detection of a solid phase in the system (the induction period, tind) ranged from tens to several hundreds
of seconds. The dependence of tind on supersaturation could be describedwithin the framework of classical nucleation theory, with
the time needed for the formation of a critical nucleus (size,10 nm) beingmuch longer than the time of the onset of particle growth.
The growth was limited by cluster diffusion kinetics. The interfacial energies of the insulin particles were determined to be 3.2–3.4
and2.2mJ/m2 at equilibrium temperatures of 25 and37C, respectively. The insulin particles formedasa result of theprocesswere
monodisperse and uniformly spherical, in clear distinction to previously reported processes of microcrystalline insulin particle
formation.
INTRODUCTION
Insulin, a 5808-Da, 51 amino acid, dual-chain hormone that
is secreted and stored in pancreatic b-cells, is therapeutically
important for the treatment of diabetes, a chronic disease that
requires supplemental insulin delivery in the form of either
solution or microcrystalline suspension formulations of
insulin (1,2). The crystal morphology inﬂuences the pharma-
cokinetics, governed by the dissolution of the microcrystals
and insulin monomer absorption into the bloodstream (3).
The pharmacokinetics of microcrystalline insulin suspen-
sions is controlled by the rate of dissociation of insulin from
the crystal lattice, dependent on the cohesive energy between
insulin molecules, crystal morphology, the dissolution rates
of different crystal faces, and the degree of disorder at the
crystal-solution interface (4).
Much progress has been made over the years in the
understanding of insulin ﬁbrillation, aggregation, and crystal
growth mechanisms (5–16). It is commonly recognized (16)
that several processes are involved in the insulin ﬁbrillation:
nucleation (formation of stable nuclei), growth of the nuclei,
and precipitation of the formed particles (ﬂocs). Nucleation
of the insulin ﬂocs typically requires temperatures above
ambient, whereas further growth of the nuclei into ﬁbrils can
occur at ambient or lower temperatures. Although not
speciﬁcally pertaining to insulin, the ﬁbril and ﬂoc formation
can be described by a nucleation-dependent elongation
mechanism (16,17). Nucleation is viewed as an assembly of
several protein monomers to form an organized structure, the
nucleus, as a precursor for formation of ﬁbrils and further
aggregation. Subsequent addition of monomers to the nu-
cleus elongates it into ﬁbrils (18).
Microcrystalline insulin typically employed in pharma-
ceutical formulations is prepared by batch crystallization
involving dissolution of the chosen insulin species in acidic
solution followed by addition of zinc chloride and other salts
and subsequent neutralization (8). Insulin microcrystal for-
mation can also be aided by organic solvents such as acetone
or phenol (19,2,4,20), which, in turn, can affect the structure
of the formed crystals. Because the aqueous solubility of
various forms of insulin is dramatically affected by temper-
ature, a polythermal method of formation of microcrystalline
insulin particles has evolved, comprising formation of the
insulin particles in acidic zinc chloride solutions at ambient
temperature, followed by adjustment of the solution to a pH
that is close to the isoelectric point of the protein (pH 5.5–
5.7) and dissolution of the insulin particles at elevated
temperatures (50–60C) to afford a clear solution (2,4,20). A
gradual cooling of such a solution yields well-deﬁned
micron-sized insulin crystals whose characteristics are de-
pendent on the species of crystallization aids, the type of
insulin used and the process parameters such as the tempera-
ture proﬁle, etc. (2,4). Interestingly, the media conditions
present during the growth of the insulin crystals also affect
the mechanism of their formation, which can occur by either
two-dimensional nucleation or screw dislocation mecha-
nisms (2,4), and can be kinetically controlled by eitherSubmitted March 23, 2005, and accepted for publication August 4, 2005.
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surface diffusion to the growing step edge or bulk volume
diffusion to the crystal-solution interface (21).
In this work, we explored a polythermal method of
microsphere formation that exploited the striking effects
of temperature on insulin solubility in aqueous solutions of
poly(ethylene glycol) (PEG). The presence of PEG allowed
the elimination of the addition of zinc salts to the protein
solution to cause protein precipitation. The facile formation
of insulin particles involved formation of supersaturated
insulin and PEG aqueous solutions at elevated temperatures
(but not exceeding the insulin thermal denaturation temper-
ature) followed by cooling of the solutions that resulted in
the insulin particle formation. The colloidal instability of
insulin that promoted ﬂocculation is established by the use of
PEG and by the choice of a pH that is close to the insulin
isoelectric point.
Despite the extensive literature dedicated to the mecha-
nisms of nucleation and crystallization of globular proteins
(see, for example, Rosenberger et al. (22)), as well as obser-
vations of insulin crystallization in aqueous solutions (23,24),
insights into crystal nucleation and growth processes involv-
ing human insulin in tertiary insulin-PEG-water systems are
lacking, mainly because of the variability of factors involved
and the experimental difﬁculty due to insulin colloidal insta-
bility in PEG solutions. This work was aimed at addressing
deﬁciencies in understanding insulin particle formation in
the presence of PEG. As described below, we have devel-
oped phase diagrams indicating boundaries of the solid-
liquid phase separation and supersaturation concentrations,
and have elucidated the mechanisms of a novel method for
the fabrication of spherical microparticles of insulin that
possess unique characteristics and utility for therapeutic drug
delivery.
EXPERIMENTAL
Materials
Human insulin USP (zinc content 0.4 wt%; lot No. XDH 1350110, Intergen,
Purchase, NY) was dispersed in solutions of 0.7 wt% NaCl and 16.6 wt%
PEG (nominal average molecular weight 3350; lot No. RP0741, Spectrum,
Gardena, CA) at various ﬁnal insulin concentrations. The pH was in all cases
adjusted to 5.65 by addition of small amounts of glacial acetic acid or 1 M
NaOH. After heating to 77C, clear protein solutions were obtained, which
were rapidly ﬁltered through Millipore (Billerica, MA) Millex 0.22-mm
syringe ﬁlters directly into scattering cells, which were sealed before use and
thermostatted at a given temperature.
Methods
Protein solubility study
In the equilibrium insulin solubility study, a tertiary insulin-water-PEG
system was chosen such that total PEG concentration was maintained at 16.6
wt%, whereas the aqueous phase consisted of 0.7 wt% NaCl solution, the pH
of which was adjusted to 5.65 by addition of minute quantities of glacial
acetic acid or 1 M NaOH. The concentration of insulin dissolved in the
aqueous phase varied, but the pH was readjusted to 5.65 after the insulin
addition. The insulin was allowed to dissolve completely at T1 ¼ 75–77C
for 4–5 min under gentle stirring resulting in an initial concentration Cin.
Then the solution temperature was changed to T2 ranging from 15 to 45C
and maintained at T2 overnight (12–16 h). The resulting opaque suspension
was then centrifuged at the temperature T2 at 13,000 3 g for 3 min and the
supernatant was removed and assayed for the equilibrium insulin concen-
tration by bicinchoninic acid (BCA) protein assay. The samples equilibrated
at T2 were kept at this temperature during both centrifugation and the protein
assay. Insulin standards for the BCA assay were diluted with a 16.6% PEG
solution to correct for PEG interference in the assay.
Dynamic light scattering study
For dynamic light scattering (DLS) kinetic measurements, an experimental
setup has been assembled (Fig. 1), comprising a 22-mWHe-Ne laser (l 632.8
nm) (Uniphase 1105P, JDS Uniphase, San Jose, CA) as a light source. The
light intensity was regulated with a beam attenuator (Newport M-925B,
Newport, Irvine, CA). Two focal length lens systems were used to focus the
incident beam on a stirred, thermostatted glass cell (Starna cells, type 37, vol
; 200 mL, pathlength, 1 mm) and the scattered beam on a narrow band
interference ﬁlter (Edmund Industrial Optics, Barrington, NJ; 632.8 nm
center, 10 nm bandwidth) to reduce stray light. The light scattered from the
solution at 90 was brought to an avalanche photodiode (EG&G Optoelec-
tronics, Gaithersburg, MD), and the photocurrent signal was processed by an
ALV-5000/E autocorrelator (ALV GmbH, Langen Germany).
A rotating magnetic motor housed in the setup drove a small stirring bar
(0.6 3 6 mm) in the lower part of the cell, similar to a setup described by
Kulkarni and Zukoski (25). A proper, complete ﬁlling of the cell with liquid
ensured the absence of the air bubbles while the cell was stirred. Control
tests without protein in the cell contents ensured the absence of spontaneous
scatterers that would be attributable to air bubbles. The temperature in the
cell was varied by two constant temperature recirculating baths (Neslab
Instruments, Portsmouth, NH), one of which was equilibrated at T1 ¼ 77C,
and another at 25 or 37C. The cell was ﬁlled with the protein plus polymer
mixture at 77C and kept at this temperature until the baths were switched by
a valve. The temperature in the cell solution was monitored by a wire
thermistor and the data were collected with a PC and processed and
transformed using autocorrelation software. In a preliminary series of
experiments, we determined the conditions where the rate of stirring
(measured in revolutions per minute (rpm)) in the scattering cell affected the
induction period and the initial rate of particle growth. The stirring was
characterized by the dimensionless Reynolds’ number Re¼ 2rUdo/h, where
FIGURE 1 DLS experimental setup.
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r is the effective radius of the particle, U [m/s] ¼ pDcell 3 rpm/60 is the
effective velocity of the particles, Dcell ¼ 0.019 m is the internal diameter of
the stirred cell, do and h are the liquid density and viscosity, respectively.
The speed of the motor rotation was measured using a digital tachometer.
At the average r ¼ RH of 100 nm, using viscosity and density values
of the16.6% PEG solution of 0.007 kg/msand 1026 kg/m3, respectively
(26), we estimated that our stirring regime only allows for laminar ﬂows
(Re , 10, rpm , 105).
At Re$ 0.03, no measurable effect of the stirring speed either on the lag
time or the slope of the kinetic curves was observed, and therefore all the
experiments described below were conducted at Re ¼ 0.03.
Continuous-angle static light scattering study
A continuous-angle static light scattering (CASLS) apparatus (Fig. 2)
consisted of the HeNe laser described above as a light source, an ellipsoidal
mirror, and a 1340 3 100 pixel charge-coupled device camera with a USB
2.0 interface (Spec-10, Roper Scientiﬁc, Trenton, NJ). Scattered light
leaving the sample cell perpendicular to the cell axis was reﬂected by the
ellipsoidal mirror and then introduced to the charge-coupled device detector.
The ellipsoidal mirror reﬂected the scattered light in an angle range of 10–
170. Scattered light from an angle ,10 and from .170 was blocked by
a pinhole block and a beam stopper, respectively (27). The scattering cells
consisted of polished borosilicate vials (I. D., 10 mm) with stoppers. The
cells were thoroughly washed using a 1.5% Tergazyme cleaning solution,
rinsed with DI and ﬁltered water, vacuum dried, and capped. The scattering
cells were equilibrated at a given temperature (60.1C) by immersion in
a thermostatted bath of toluene used for scattering calibration. Temperature
quenching was accomplished by withdrawing the 77C toluene in which the
cell was immersed, switching the programmable baths (Neslab Instruments)
to T2 ¼ 25C, and rapidly ﬁlling the cell immersion bath with toluene
preequilibrated at 25C. The temperature inside the scattering cells was
monitored in a control series of experiments, and the time to establish the T2
was found to be ,1 min. Therefore, the time count and scattering intensity
readings commenced at t ¼ 1.0 min in all subsequent experiments.
To calculate the temporal evolution of the radii of gyration of scatterers
(Rg) and the fractal dimension of the aggregating clusters (d), we applied
a Berry plot relating the Raylegh ratio, R, at the scattering angle, u, the
apparent molecular weight of the scatterers, Mw, the concentration of
scatterers, and the scattering function, P(u), with the optical constant, K (28):
ðKc=RðuÞc¼0 ¼ 1=MWPðuÞ; (1)
where the optical constant, K, is
K ¼ 4p2n2ðdn=dcÞ2=NAl4; (2)
and the scattering vector, q, is deﬁned as q ¼ 4pn sinðu=2Þ=l:
Because P(u) ¼ 2(ex  11 x)/x2 and x ¼ q2Rg (29), the Berry equation
can be rearranged as:
ðKc=RðuÞc¼0Þ0:5 ¼ ð1=MWÞ0:5ð11 q2Rg=6Þ: (3)
Herein, n, dn/dc, l, and NA denote refractive index of the solvent, the
speciﬁc refractive index increment, the wavelength of the laser light, and
Avogadro’s number, respectively. A BI-DNDC differential refractometer
(Brookhaven Instruments, Holtsville, NY) was used in a static mode to
measure the speciﬁc refractive index increment, dn/dc.
Under the condition of qRg  1, i.e., in the range of high-q, the fractal
dimension, d, was deﬁned from the classic expression:
IðqÞ ¼ const x qd: (4)
However, in the cases when qRg was close to unity, a more complex
expression (30) was applied:
FðqRgÞ ¼ sin½ðd  1Þarctanðq=RgÞ=
ðd  1ÞqRgð11 q2RgÞðd1Þ=2; (5)
where F(qRg) } I(q) is the scale factor of scatterers.
RESULTS AND DISCUSSION
Solubility diagram
Knowledge of equilibrium protein concentrations as a func-
tion of temperature at certain solution conditions is required
to decipher the role of an additive such as PEG on the protein
nucleation rate and growth kinetics (25). In general, lower
supersaturation results in slower protein crystal nucleation
and longer induction times (25,31,32). Nucleation rates of
proteins are typically enhanced in the presence of polymer
(31,32). To establish the equilibrium insulin solubility (C*¼
Ceq at large Cin) in the presence of PEG at a temperature T2,
several Cin values were used, spanning a range of concen-
trations from 0.4 to 3.5 mg/mL (Fig. 3). The C* was deﬁned
as the plateau concentration reached on the Ceq vs. Cin plot at
a given temperature. Fig. 3 shows that the insulin solubility
increased with temperature, i.e., dC*/dT . 0. Thus, at the
FIGURE 2 CASLS experimental setup.
FIGURE 3 Dependence of the equilibrium insulin concentration reached
at a given temperature T2, on the initial insulin concentration at T1¼ 77C in
aqueous 16.6 wt% PEG solutions.
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same concentration Cin, the supersaturation S ¼ Cin/C* de-
creases with increasing T. The solid-liquid saturation curve
(Fig. 4) was obtained by ﬁtting the experimental data by an
exponential equation representing the expansion of the van’t
Hoff relation around a reference temperature (T2 ¼ 298
K) (25,33):
Csat ¼ Cexp DH
kT2
Tsat  T2
T2
 
; (6)
where C* ¼ Csat(T2 ¼ 298 K), k ¼ 1.38 3 1023 J/K is the
Boltzmann constant and DH, the enthalpy is derived from
ﬁtting the data to Eq. 6.
Fitting Eq. 6 to the experimental data yielded an estimate
of DH  5 3 1023 J, on the order of 1–2 kT2. Thus, the
derived DH/kT2 value for this system is an order of mag-
nitude lower than the value of 20–30 found for the well-
studied lysozyme/PEG/water ternary system (25,34), indicating
a much higher propensity of the insulin to aggregate in the
presence of PEG than does lysozyme. As shown below, very
high nucleation rates in such a system were found.
DLS study of nucleation and growth kinetics
Induction period and particle number as functions of
supersaturation concentration
The time elapsed from the moment of creation of a super-
saturated solution and the detection of a new (solid) phase in
the system is called the induction period (tind) as deﬁned in
So¨hnel and Mullin (35). The induction periods for human Zn
insulin nucleation and crystallization kinetics in the absence
of PEG have been studied recently by confocal laser scan-
ning microscopy (23,24). At initial insulin concentrations of
1.8–3.5 mg/mL, the tind until the appearance of the ﬁrst
observable crystallites ranged from 1.5 to 8 h. Mu¨hlig et al.
(23) concluded that for solute supersaturations of up to 3.5,
the growth started from a few active insulin precipitate par-
ticles whereas the three-dimensional nucleation was negli-
gible for observation times of up to 24 h.
In our case, where supersaturation was created by rapid
cooling of a ternary insulin-PEG-water system, the value of
tind was dependent on the degree of supersaturation and on
the temperature T2. The tind values found were on the order of
tens to a few hundreds of seconds (Fig. 5) and were typically
much shorter than the lag times described in the literature
(15,16,36), which is intuitively understood by the worsening
of the solvent due to the presence of large concentrations
(16–17 wt%) of the protein-incompatible PEG.
We attempted to rationalize the experimentally observed
tind values. It must be noted that the induction period is not
a fundamental, inherent property of the system because the
detection of the new solid phase depends on the detection
method used. However, it has long been recognized that
some time must elapse between the creation of the super-
saturation condition and the detection of a new phase in a
system (35). Because the tind was determined by the onset of
a rapid raise of the relative intensity of the scattering light,
characteristic of the early appearance of a solid phase, the tind
could be represented as the sum of two parameters:
tind ¼ tn1 tg; (7)
where tn is the nucleation time and tg is the growth time, i.e.,
the time required for the nucleus to grow to a size measurable
by our detection method (rH $ 1 nm).
The tn and tg in Eq. 7 depend on the kinetic mechanism of
the nucleation and particle growth, respectively. The nucleation
in our system is created by the rapid cooling of the system,
a cooling that can be assumed to be instantaneous (Fig. 5).
The steady-state nucleation rate (Js) is reached once a steady-
state size distribution of the nuclei is achieved, because the
steady-state size distribution of nuclei spans all sizes up to
the critical nucleus size (R*).
FIGURE 4 Equilibrium insulin solubility at different temperatures in 16.6
wt% aqueous PEG solutions at pH 5.65. Symbols represent experimental
data whereas the solid line is the ﬁt to the van‘t Hoff’s expansion (Eq. 1).
FIGURE 5 Experimental measurement of the nucleation induction time
(tind). The temperature ramp employed by using two temperature
recirculation baths is shown by a solid line, whereas the relative scattering
intensity at 90 as a function of time is depicted by open circles. Initial
insulin concentration, Cin¼ 0.86 mg/mL; supersaturation, S¼ Cin/C*¼ 3.4.
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The critical nucleus size (R*) can be estimated using the
same assumptions (25):
R
 ¼ ðpr3gs=3kBT ln SÞ: (8)
At the insulin monomer radius r ¼ 1.3 nm (37), the
interfacial energy gs¼ 3.103 J/m2 (23), T¼ 298 K, and S¼
3.4, we obtain R*  1.3 nm from Eq. 8. The critical nu-
cleation radius is thus that of the insulin monomer, which is
in line with the notion of the extremely rapid nucleation and
rapid dissociation. One must note, however, that when
a suspension of particles is suddenly quenched to a temper-
ature below the particle solubility, as in our case, the nuclei
must grow to a size larger than R* to be thermodynamically
stable (25).
The scattering intensity depends on the concentration and
size of scattering units in the insulin suspension. Thus, the
data in Fig. 5 contain information about both cluster density
and cluster size. As demonstrated by Kulkarni and Zukoski
(25), deconvolution of the light scattering signal into the rate
of nucleation and the rates of cluster growth requires a de-
tailed model accounting for the time evolution of cluster size
distribution for all sizes. Unfortunately, such models are cur-
rently unavailable. We followed a number of works on nu-
cleating systems, which assumed that nucleation is slow
compared to the rate of growth of clusters once they are larger
than R*. The experimentally measured induction period is
then proportional to the inverse of the steady-state nucleation
rate:
tind ¼ BexpðDG=kBTÞ; (9)
where B is a preexponential factor associated with the pre-
factor in J.
For a ﬁxed value of prefactor B, if the interfacial tension is
weakly dependent on temperature and protein concentration,
a linear dependence of
lnðtindÞ;1=ðln SÞ2; (10)
is then expected (38,35).
We applied the above expression of the classical nu-
cleation theory to our experimental data. Fig. 6 depicts the
tind data points as a function of supersaturation expressed in
terms of Eq. 10. As is seen, the data indicate a linear trend as
predicted by Eq. 10 quite strongly. The assumption of ho-
mogeneous nucleation and formation of spherical particles
yields the following expression for the effective interfacial
energy (31,32):
gs ¼ kBT
16p
3n
2 B
 1=3
; (11)
where B is the slope of the linear ﬁts in Fig. 6.
Using the average molecular weight of 11 kg/mol, density
of solid insulin of 1200 kg/m3 (24), and slopes in Fig. 6, we
calculated an effective interfacial energy (gs) of the insulin
particles from Eq. 11. The determined gs values were equal to
3.2–3.4 mJ/m2 for the insulin systems at equilibrium tem-
perature 25C and 2.2 mJ/m2 for the systems equilibrated at
37C. A slightly lower interfacial energy is expected at
higher temperature. Importantly, the obtained values corre-
late well with previously reported values for interfacial en-
ergies of proteins in general (25,39,40,31,32) and in
particular, excellent correlation was observed with the spe-
ciﬁc free surface energy of the crystalline state of human
insulin, estimated to be ;3 mJ/m2 (24). Interestingly, a
twofold increase in PEG concentration did not change the
surface energy of the resulting insulin particles, but signif-
icantly lowered the induction time at the same supersatura-
tion levels. Analogous results have been observed by
Kulkarni and Zukoski (25,34) for the nucleation of lysozyme
in the presence of PEG.
The effective growth rate
The effective growth rate of the insulin particles was exper-
imentally determined as follows. The relative intensity data
were analyzed by nonlinear constrained regularization (Non-
Lin routine) of the autocorrelation function taken every 10 s
(appropriate for the timescales observed) using delay times
of 2–2000 ms (41). The autocorrelation functions yielded the
distributions of the diffusion coefﬁcients of the scatterers and
the corresponding hydrodynamic radii. A typical time
evolution of the hydrodynamic radii of the insulin particles
is depicted in Fig. 7. As is seen, the effective rate of particle
growth was 1–2 nm/s in the range 200–400 s. In this time
range, an initial steady-state growth was achieved (compare
with Fig. 5). The initial growth rate roughly corresponds to
the values of the lateral growth rate of human insulin crystals
FIGURE 6 Induction period (tind) as a function of supersaturation, plotted
as ln(tind) versus 1/(ln S)
2 (see Eq. 4). Open circles (trendline 1) represent
data for the following conditions: NaCl, 0.7%; PEG 3350, 8.3%; pH 5.65;
25C. Solid circles (trendline 2) show data for NaCl, 0.7%; PEG 3350,
16.6%; pH 5.65; 25C. Triangles (trendline 3) depict data for NaCl, 0.7%;
PEG 3350, 16.6%; pH 5.65; 37C. Diamonds (trendline 4) show data for
NaCl, 1.4%; PEG 3350, 16.6%; pH 5.65; 25C. Initial temperature, 77C.
Solid lines are linear ﬁts to the data (R2 . 0.986 in all cases).
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measured at similar supersaturations by in situ microscopic
observation (24). As expected, the effective growth rate of
the insulin particles steadily increased with supersaturation
(22,42) (Fig. 8). Although the mechanisms of the particle
growth cannot be unambiguously identiﬁed from our
experiments, it appears that although the nucleation rates
are much higher, the estimated effective particle growth rates
are close to the ones observed in crystal growth in solutions
of insulin and other proteins (22,42) (Fig. 8). Transport-
limited crystal growth rates in solutions of inorganic
compounds are typically 2–3 orders of magnitude higher
(43). Because we only observed the initial stages of particle
growth, such growth rates can be controlled by combined
transport-controlled and kinetically controlled mechanisms,
each of which can dominate at various stages of particle
growth (43).
SLS study of the nucleation and growth
As we have demonstrated above, the liquid-solid phase
separation in the supersaturated insulin/PEG ternary systems
occurs rapidly under the temperature quench conditions. We
were interested to explore the early stages of the insulin
aggregation process. Fig. 9 shows the relationship between
relative scattering intensity I(q) and the scattering vector, q,
when the temperature was quenched from 77 to 25C.
As is seen, the scattering intensity grew severalfold at the
forward angles over time, exhibiting rather monotonic de-
pendencies within the studied range of the scattering angles.
These dependencies were devoid of peaks characteristic
of spinodal decomposition observed at q , 103 nm1 in
aqueous salt solutions of lysozyme (44). It must be noted,
however, that the range of very low scattering angles re-
quired for measurements at q , 103 nm1 was not available
with our experimental setup but could be investigated using
other methods, such as x-ray or neutron scattering. In the q
range studied, the shape of the I(q) vs. q curves resembled
that previously observed under the temperature quench
conditions with lysozyme (44) as well as with a membrane
protein, the bc1 complex, in aqueous PEG solutions (29).
When plotted in double logarithmic coordinates, the I(q) vs. q
dependencies provided useful scaling information about the
structure of the forming aggregates and dominating mech-
anisms of their formation (45). Initially, the scattering inten-
sity was almost independent of the scattering angle, which
denoted that there were only small (1–10 nm) scatterers in
the solution. Over time, these small scatterers associated
FIGURE 7 Time evolution of the hydrodynamic radius of insulin
particles. Initial insulin concentration, Cin ¼ 0.86 mg/mL; supersaturation,
S ¼ Cin/C* ¼ 3.4. Inset shows the effective particle growth rate computed
using the average dRH/dt data.
FIGURE 8 Effect of supersaturation on the effective particle growth rate
averaged over 200–400 s of the kinetics. The concentration of insulin was
varied, whereas a PEG concentration of 16.6 wt% and T2 ¼ 25C was
maintained throughout.
FIGURE 9 Typical continuous-angle SLS distributions from a 0.86 mg/mL
insulin/16.6% PEG solution after a temperature quench from 77 to 25C.
Numbers stand for time in seconds. Only every 10th data point is shown for
clarity. The solid line depicting a slope of1.8 characteristic of the case of the
diffusion-limited cluster-cluster aggregation is shown to guide the eye only.
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to form large clusters whose structure factor resulted in the
appearance of an angular dependence to the scattering in-
tensity. Typically, in our CASLS experiments we were
limited by the initial 5–10 min of the particle formation,
because of the increment of turbidity, multiple scattering,
and sedimentation phenomena at later stages. After ;10
min, the relative intensity, I(q), had a slowly evolving an-
gular dependence, and the DLS results indicated that the
average particle size was gradually increasing. This behavior
is typical for the presence of scattering by fractal structures.
In the range of large scattering vectors and with the forming
particles approaching micron size, where the condition
qRg  1 was satisﬁed, our data scaled as I(q) } q1.8
(Fig. 10), indicating the case of a diffusion-limited cluster-
cluster aggregation (46,47).
The temporal evolution of the hydrodynamic radii (RH)
and the fractal dimension are presented in Fig. 10. Particles
of critical size Rg  170 nm, which were reported by Sluzky
et al. (13) to be a nucleating species in the process of human
insulin aggregation, formed after ;110 s, after which the
increase of the Rg values accelerated. There was a fair cor-
respondence of the Rg values to the radii found in our earlier
DLS experiments. However, no signiﬁcant lag time in the
increase of the Rg values was found in the CASLS setup,
unlike in the DLS experiments, which can be explained by
the differences in the kinetics of the temperature quench.
That is, whereas in the DLS setup the equilibration of the cell
at the T2 was almost instantaneous (1–2 s), in the CASLS
the time to establish the T2 was up to 1 min because of the
signiﬁcant volume of the scattering cell. The heat transfer
parameters obviously affect the induction period. The fractal
dimension with scaling d ¼ 1.8 evolving after ;5 min
indicated a diffusion-limited cluster-cluster aggregation (48–
51). Two types of cluster-cluster aggregation have been
studied intensively: ﬁrst, reaction limited cluster aggrega-
tion, and second, diffusion limited cluster aggregation (52).
Fractal dimensions predicted by these models are 2.11 for
reaction limited cluster aggregation and 1.75 for diffusion
limited cluster aggregation, respectively.
The obtained fractal dimension suggests that the insulin
particles have a fractal network structure. This structure is
consistent with the mechanism of the particle formation,
where growing insulin ﬁbrils encounter other ﬁbrils and link
together to form junctions. Insulin monomers, dimers, and,
to a lesser degree (15,16), hexamers initiate formation of
amyloidogenic nuclei (53) and subsequent formation of
ﬁbrils and of chains that can branch at random locations.
Such a growth mechanism will produce self-similar, micro-
crystalline patterns in insulin ﬁbrils that have been reported
(54). Notably, aggregation of insulin in acidic, denaturing
media in the absence of PEG has been reported to result in
rather well-organized three-dimensional ﬁbrillar structures
(15,16,55,56). It can be hypothesized that the presence of the
large concentrations of PEG altered the mechanism of the
insulin aggregation, perhaps by introducing depletion in-
teractions. In addition, we conducted our studies at pH’s
close to the isoelectric point of insulin, where electrostatic
repulsion is suppressed whereas long-lived associations dom-
inate. Formation of fractal structures upon temperature-
induced protein aggregation, especially in the presence of
polymeric aggregation aids, is well established (57,58).
To assess the size and shape of the particles formed at the
ﬁnal stages of aggregation, the contents of the scattering cell
equilibrated at T2 ¼ 25C in the above CASLS experiment
for 0.5 h were agitated by brief vortexing and diluted 100-
fold into another scattering cell ﬁlled with 16.6% PEG
solution preequilibrated at 25C. The contents of the scat-
tering cell were brieﬂy (2–3 s) sonicated to ensure the
absence of air bubbles, and the CASLS measurement was
conducted every 2 s for the next 10 s. No signiﬁcant dif-
ferences in the intensity distributions were observed, which
FIGURE 10 Temporal evolution of the radius of gyration of scatterers
(Rg) and the fractal dimension of insulin aggregates after a temperature
quench. Conditions as in Fig. 9.
FIGURE 11 Continuous-angle SLS distributions from a suspension of
insulin particles evolved in the CASLS experiment (Fig. 2), followed by
dilution, after 0.5 h. See text for details of the measurement. Data are
averaged, and only every 100th data point is shown for clarity. Solid line
illustrating a slope of 4.0, characteristic of the globular particles (micro-
spheres), is shown to guide the eye only.
3430 Bromberg et al.
Biophysical Journal 89(5) 3424–3433
indicated the absence of particle sedimentation within this
period of time. The average I(q) vs. q plot that resulted (Fig.
11) shows a dramatic increase of the scaling exponent d
(compare with Fig. 10), which was estimated to be 4.0. This
scaling exponent (so-called Porod exponent) is typical for
particles with mass and surface dimensionalities (dm and ds,
respectively), for which the following scaling dependence
holds (under the condition qRg  1) (44):
IðqÞ} qð2dfdsÞ: (12)
It appears that the insulin particles formed under these
conditions evolved into globular structures (microspheres)
(df ¼ 3.0) with sharp boundaries (ds ¼ 2.0) (59).
The relative size distribution of the microspheres in the
same dispersion was estimated from the DLS-mode measure-
ments (Fig. 2), where the size distribution function was cal-
culated using the method of nonnegatively constrained least
squares (Fig. 12). The microspheres obtained as in Fig. 11
were separated by ﬁltration and were repeatedly washed by
deionized water to eliminate the interference of PEG in the
G(dg) measurement. The well-deﬁned peak due to the insulin
particles indicated that the size distribution was relatively
narrow. Notably, similar distributions were observed at
several scattering angles, which strengthens the validity of
the interpretation. These results were further visualized by
using scanning electron microscopy of the insulin particles
obtained by the above heating-cooling process in the pres-
ence of 16.6% PEG followed by washing as above to remove
PEG (Fig. 13). The scanning electron microscopy showed
uniformly spherical particles of 1–2-mm size, in excellent
agreement with the light scattering results (Fig. 12). It
appears, therefore, that we have found thermodynamic con-
ditions favoring the formation of unique spherical insulin
particles. Considering the Helmholtz free energy for micro-
crystallites, Abraham (60) showed a decrease of the free
energy with the increase of the cluster size for spherical
clusters and noted that the spherical shape was one of the
minimal free energy conﬁgurations.
CONCLUDING REMARKS
Formation of particles of human insulin in insulin-PEG-
water ternary systems upon rapid cooling has been studied
by light scattering techniques, with the emphasis on the ki-
netics of the nucleation and growth processes. Conventional
methods of microcrystalline insulin particle preparation were
modiﬁed by the presence of PEG and by fabrication at pH’s
close to the protein’s isoelectric point to facilitate both
nucleation and growth. A steady-state nucleation rate was
achieved within milliseconds, but the particle growth was
preceded by an induction period. The dependence of the
induction period on supersaturation could be described within
the framework of classical nucleation theory. Of signiﬁcant
importance to pharmaceutical applications, the insulin par-
ticles formed by this process are relatively monodisperse and
uniformly spherical.
Models that describe the kinetics of formation of uni-
formly sized, spherical colloids of inorganic compounds are
fairly well known (61–65). Such models imply formation of
nuclei that are rapidly produced in supersaturated solutions
and then grow to nanosize primary particles, which then
irreversibly coagulate to form much larger colloids. The for-
mation of the primary particles is governed by the surface
tension, which is minimal for spherical nuclei. The growth of
the secondary particles is facilitated by the reduction of the
FIGURE 12 Distribution of the effective hydrodynamic diameter (dg) of
insulin microspheres obtained at three scattering angles.
FIGURE 13 Scanning electron microscopy microphotograph of insulin
particles obtained by cooling of a supersaturated insulin/PEG aqueous solu-
tion at pH 5.65, PEG concentration of 16.6 wt%, and a supersaturation of 3.4.
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surface potential at pH’s near the isoelectric point, resulting
in reduction of electrostatic barriers, thus promoting rapid
irreversible particle aggregation. Formation of the secondary
particles, which can be of a narrow size distribution, is as-
sumed to be a diffusion-controlled process (65). This descrip-
tion seems to be in overall accord with our observations.
Numerical simulations indicate (66) that the protein nuclea-
tion can be a two-step process. First, a nucleus forms and
grows as a disordered, liquid-like aggregate until it reaches
a critical size (several hundred units), and whereupon crystal
nucleation becomes possible. The liquid-like state differ-
entiates the protein ‘‘primary particle’’ from its crystalline
inorganic counterparts (65), but kinetic mechanisms of the
growth into larger, ‘‘secondary’’ crystalline particles perhaps
are not much dissimilar. Notably, the previously identiﬁed
insulin forms that result from insulin crystallization in acidic
aqueous/acetone solutions in the presence of zinc salts grow
by the generation and spreading of crystal layers, with linear
kinetics (67). A novel process for the formation of phar-
maceutically valuable insulin microspheres via a previously
unknown mechanism of insulin particle formation has been
devised. Microspheres with a mean aerodynamic diameter of
1–3 mm with a narrow particle size distribution are parti-
cularly valuable for particles to be delivered by the pulmo-
nary route, because it results in ideal aerodynamic performance,
delivery of therapeutics to the deep lung, and the potential
for achievement of very high systemic bioavailability.
We thank Larry Brown and Jack McGeehan for helpful discussions.
The process of microsphere fabrication, termed PROMAXX, is a registered
trademark of Baxter International, its subsidiaries, or afﬁliates. Epic
Therapeutics is a wholly owned subsidiary of Baxter Healthcare Corp-
oration.
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